VANCOMYCINE SANDOZ 500 mg, powder for concentrate for infusion or for oral solution 10 bottles of 13.5 ml
Active ingredients: Vancomycin, Vancomycin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusion or oral solution10 bottles of 13.5 mlintrapéritonéale;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VANCOMYCINE SANDOZ 500 mg, poudre pour solution à diluer pour perfusion ou pour solution buvable
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion ou buvable
- Route of administration
- intrapéritonéale;intraveineuse
- Presentation description
- 10 flacon(s) en verre de 13,5 ml
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64022454CIP75661338CIP133400956613380Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VANCOMYCINE (CHLORHYDRATE DE)poudre | 500 mg · un flacon | SA |
| VANCOMYCINEpoudre | 500 000 UI · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.